AVNS
HealthcareAvanos Medical, Inc.
$11.31
+$0.13 (+1.16%)
Jan 5, 2026
Price History (1Y)
Analysis
Avanos Medical, Inc. is a healthcare company operating in the medical devices industry with 2,227 employees. The company has a market capitalization of $525.00 million and generates revenue of approximately $699.90 million. The company's financial health is marked by significant losses, with a net income of -$468,600,000 over the trailing twelve months. Its gross margin stands at 52.3%, while its operating and profit margins are 0.3% and -67.0%, respectively. Avanos Medical has positive return on assets (ROA) at 1.6%, but a negative return on equity (ROE) of -46.7%. The company's balance sheet shows debt of $133.70 million and cash reserves of $70.50 million, resulting in a debt-to-equity ratio of 17.18. Avanos Medical's valuation context is marked by a forward price-to-earnings ratio of 11.91 and an enterprise value to earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio of 7.81. The company has experienced revenue growth of 4.3% year-over-year, but its earnings growth is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Avanos Medical, Inc.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Visit website →Key Statistics
- Market Cap
- $525.00M
- P/E Ratio
- N/A
- 52-Week High
- $17.69
- 52-Week Low
- $9.30
- Avg Volume
- 503.68K
- Beta
- 1.08
Company Info
- Industry
- Medical Devices
- Exchange
- NYQ
- Country
- United States
- Employees
- 2,227